Noble Wealth Management PBC Makes New $155,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Noble Wealth Management PBC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 306 shares of the healthcare conglomerate’s stock, valued at approximately $155,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Fisher Asset Management LLC lifted its holdings in UnitedHealth Group by 7.4% during the 4th quarter. Fisher Asset Management LLC now owns 3,434,467 shares of the healthcare conglomerate’s stock valued at $1,737,360,000 after purchasing an additional 237,300 shares during the last quarter. Maripau Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $436,000. Maple Capital Management Inc. raised its holdings in UnitedHealth Group by 1.6% in the 4th quarter. Maple Capital Management Inc. now owns 67,732 shares of the healthcare conglomerate’s stock valued at $34,263,000 after acquiring an additional 1,066 shares during the period. Sims Investment Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $522,000. Finally, SVB Wealth LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $12,015,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on UNH shares. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $474.95 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market cap of $437.09 billion, a PE ratio of 30.64, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm’s fifty day moving average price is $516.59 and its two-hundred day moving average price is $557.04.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.